paroxetine has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, L; Kaynak, S; Kaynak, T; Kocak, N; Ozerdem, A | 1 |
| Hough, DW; Strickland, GM | 1 |
| Aaberg, TM; Greiner, K; Hejny, C; Lawson, DH; Sternberg, P | 1 |
3 other study(ies) available for paroxetine and Day Blindness
| Article | Year |
|---|---|
Disappointment of patients on antidepressant therapy after excimer laser treatment.
Topics: Adult; Alprazolam; Antidepressive Agents; Dry Eye Syndromes; Female; Humans; Keratomileusis, Laser In Situ; Middle Aged; Mydriasis; Myopia; Paroxetine; Patient Satisfaction; Patients; Sertraline; Vision Disorders | 2006 |
Unilateral facial numbness and visual blurring associated with paroxetine discontinuation.
Topics: Antidepressive Agents, Second-Generation; Diagnosis, Differential; Facial Nerve Diseases; Humans; Hypesthesia; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Vision Disorders | 2000 |
Retinopathy associated with high-dose interferon alfa-2b therapy.
Topics: Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Fundus Oculi; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Paroxetine; Recombinant Proteins; Retinal Diseases; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Vision Disorders | 2001 |